DOI QR코드

DOI QR Code

Human Development Inequality Index and Cancer Pattern: a Global Distributive Study

  • Rezaeian, Shahab (Social Development & Health Promotion Research Center, Gonabad University of Medical Sciences) ;
  • Khazaei, Salman (Department of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences) ;
  • Khazaei, Somayeh (Rafsanjan University of Medical Sciences) ;
  • Mansori, Kamyar (Department of Epidemiology, School of Medicine, Kurdistan University of Medical Sciences) ;
  • Moghaddam, Ali Sanjari (School of Medicine, Shahid Beheshti University of Medical Sciences) ;
  • Ayubi, Erfan (School of Public Health, Shahid Beheshti University of Medical Sciences)
  • 발행 : 2016.06.01

초록

This study aimed to quantify associations of the human development inequality (HDI) index with incidence, mortality, and mortality to incidence ratios for eight common cancers among different countries. In this ecological study, data about incidence and mortality rates of cancers was obtained from the Global Cancer Project for 169 countries. HDI indices for the same countries was obtained from the United Nations Development Program (UNDP) database. The concentration index was defined as the covariance between cumulative percentage of cancer indicators (incidence, mortality and mortality to incidence ratio) and the cumulative percentage of economic indicators (country economic rank). Results indicated that incidences of cancers of liver, cervix and esophagus were mainly concentrated in countries with a low HDI index while cancers of lung, breast, colorectum, prostate and stomach were concentrated mainly in countries with a high HDI index. The same pattern was observed for mortality from cancer except for prostate cancer that was more concentrated in countries with a low HDI index. Higher MIRs for all cancers were more concentrated in countries with a low HDI index. It was concluded that patterns of cancer occurrence correlate with care disparities at the country level.

키워드

참고문헌

  1. Akinyemiju TF (2012). Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. PLoS One, 7, 4883-4.
  2. Batouli A, Jahanshahi P, Gross CP, et al (2014). The global cancer divide: Relationships between national healthcare resources and cancer outcomes in high-income vs. middle-and low-income countries. J Epidemiol Glob Health, 4, 115-24. https://doi.org/10.1016/j.jegh.2013.10.004
  3. Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
  4. Coughlin SS, Berkowitz Z, Hawkins NA, et al (2007). Breast and colorectal cancer screening and sources of cancer information among older women in the united states: results from the 2003 health information national trends survey. Prev Chronic Dis, 4, A57.
  5. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  6. Forman D, de Martel C, Lacey CJ, et al (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30, F12-F23. https://doi.org/10.1016/j.vaccine.2012.07.055
  7. Hébert JR, Daguise VG, Hurley DM, et al (2009). Mapping cancer mortality to incidence ratios to illustrate racial and sex disparities in a high-risk population. Cancer, 115, 2539-52. https://doi.org/10.1002/cncr.24270
  8. Hu Q-D, Zhang Q, Chen W, et al (2013). Human development index is associated with mortality-to-incidence ratios of gastrointestinal cancers. World J Gastroenterol, 19, 5261. https://doi.org/10.3748/wjg.v19.i32.5261
  9. Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  10. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907. https://doi.org/10.1158/1055-9965.EPI-10-0437
  11. Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50. https://doi.org/10.1200/JCO.2005.05.2308
  12. Myers ER, Moorman P, Gierisch JM, et al (2015). Benefits and harms of breast cancer screening: a systematic review. JAMA, 314, 1615-34. https://doi.org/10.1001/jama.2015.13183
  13. Patel AR, Prasad SM, Shih Y-CT, et al (2012). The association of the human development index with global kidney cancer incidence and mortality. J Urol, 187, 1978-83. https://doi.org/10.1016/j.juro.2012.01.121
  14. Porter PL (2009). Global trends in breast cancer incidence and mortality. Salud Publica Mex, 51, 141-6. https://doi.org/10.1590/S0036-36342009000800003
  15. Sunkara V, Hebert JR (2015). The colorectal cancer mortality to incidence ratio as an indicator of global cancer screening and care. Cancer, 121, 1563-9. https://doi.org/10.1002/cncr.29228
  16. Vostakolaei FA, Karim-Kos HE, Janssen-Heijnen ML, et al (2011). The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health, 21, 573-7. https://doi.org/10.1093/eurpub/ckq120
  17. Youlden DR, Cramb SM, Dunn NA, et al (2012). The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol, 36, 237-48. https://doi.org/10.1016/j.canep.2012.02.007